Home
AMPH
AMPH News

Latest Amphastar Pharmaceuticals Inc. (AMPH) News on January 24, 2025

Argus Research

3 days ago

AMPH: Lowering target price to $38.00

Argus Research

10 days ago

AMPH: Raising target price to $40.00

Amphastar Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

ACCESSWIRE

16 days ago

Amphastar Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Argus Research

a month ago

AMPH: Lowering target price to $41.00

Argus Research

a month ago

AMPH: Lowering target price to $43.00

MT Newswires

a month ago

Amphastar Pharmaceuticals Insider Sold Shares Worth $672,815, According to a Recent SEC Filing

Argus Research

a month ago

AMPH: Lowering target price to $46.00

Should You Be Adding Amphastar Pharmaceuticals (NASDAQ:AMPH) To Your Watchlist Today?

Simply Wall St.

2 months ago

Should You Be Adding Amphastar Pharmaceuticals (NASDAQ:AMPH) To Your Watchlist Today?

Implied Volatility Surging for Amphastar Pharmceuticals (AMPH) Stock Options

Zacks

2 months ago

Implied Volatility Surging for Amphastar Pharmceuticals (AMPH) Stock Options

Argus Research

2 months ago

AMPH: Raising target price to $47.00

Why Amphastar Pharmaceuticals (AMPH) Is One of the Most Profitable Pharmaceutical Stocks Right Now?

Insider Monkey

2 months ago

Why Amphastar Pharmaceuticals (AMPH) Is One of the Most Profitable Pharmaceutical Stocks Right Now?

Argus Research

2 months ago

AMPH: What does Argus have to say about AMPH?

Amphastar Pharmaceuticals to Present at the 36th Annual Piper Sandler Healthcare Conference

ACCESSWIRE

2 months ago

Amphastar Pharmaceuticals to Present at the 36th Annual Piper Sandler Healthcare Conference

Amphastar initiated with an Equal Weight at Wells Fargo

TipRanks

2 months ago

Amphastar initiated with an Equal Weight at Wells Fargo

Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference

ACCESSWIRE

2 months ago

Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference

Argus Research

2 months ago

AMPH: Lowering target price to $50.00

Amphastar Pharmaceuticals Third Quarter 2024 Earnings: Misses Expectations

Simply Wall St.

3 months ago

Amphastar Pharmaceuticals Third Quarter 2024 Earnings: Misses Expectations

Thomson Reuters StreetEvents

3 months ago

Q3 2024 Amphastar Pharmaceuticals Inc Earnings Call

GuruFocus.com

3 months ago

Amphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings Call Highlights: Resilient Revenue Growth ...

Here's What Key Metrics Tell Us About Amphastar (AMPH) Q3 Earnings

Zacks

3 months ago

Here's What Key Metrics Tell Us About Amphastar (AMPH) Q3 Earnings

Amphastar Pharmaceuticals (AMPH) Lags Q3 Earnings and Revenue Estimates

Zacks

3 months ago

Amphastar Pharmaceuticals (AMPH) Lags Q3 Earnings and Revenue Estimates

Associated Press Finance

3 months ago

Amphastar: Q3 Earnings Snapshot

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2024

ACCESSWIRE

3 months ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2024

Argus Research

3 months ago

AMPH: What does Argus have to say about AMPH?

Amphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings Report Preview: What to Expect

GuruFocus.com

3 months ago

Amphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings Report Preview: What to Expect

BridgeBio Pharma (BBIO) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Zacks

3 months ago

BridgeBio Pharma (BBIO) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Amphastar Pharmaceuticals (AMPH) Expected to Beat Earnings Estimates: Should You Buy?

Zacks

3 months ago

Amphastar Pharmaceuticals (AMPH) Expected to Beat Earnings Estimates: Should You Buy?

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6, 2024

ACCESSWIRE

3 months ago

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6, 2024

Are Investors Undervaluing Amphastar Pharmaceuticals (AMPH) Right Now?

Zacks

3 months ago

Are Investors Undervaluing Amphastar Pharmaceuticals (AMPH) Right Now?

Will Amphastar (AMPH) Beat Estimates Again in Its Next Earnings Report?

Zacks

3 months ago

Will Amphastar (AMPH) Beat Estimates Again in Its Next Earnings Report?

Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Stock Is Going Strong: Is the Market Following Fundamentals?

Simply Wall St.

3 months ago

Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Stock Is Going Strong: Is the Market Following Fundamentals?

Is Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) The Top Stock With Improving Technical Ratings According To Piper Sandler?

Insider Monkey

3 months ago

Is Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) The Top Stock With Improving Technical Ratings According To Piper Sandler?

Argus Research

4 months ago

AMPH: Lowering target price to $49.00

Implied Volatility Surging for Amphastar Pharmaceuticals (AMPH) Stock Options

Zacks

4 months ago

Implied Volatility Surging for Amphastar Pharmaceuticals (AMPH) Stock Options

Amphastar Pharmaceuticals (NASDAQ:AMPH) jumps 10% this week, though earnings growth is still tracking behind three-year shareholder returns

Simply Wall St.

4 months ago

Amphastar Pharmaceuticals (NASDAQ:AMPH) jumps 10% this week, though earnings growth is still tracking behind three-year shareholder returns

Insider Sale: Director Floyd Petersen Sells Shares of Amphastar Pharmaceuticals Inc (AMPH)

GuruFocus.com

5 months ago

Insider Sale: Director Floyd Petersen Sells Shares of Amphastar Pharmaceuticals Inc (AMPH)

Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference

ACCESSWIRE

5 months ago

Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference

Argus Research

5 months ago

AMPH: Raising target price to $51.00

Argus Research

5 months ago

AMPH: Raising target price to $48.00

MT Newswires

5 months ago

Amphastar Pharmaceuticals Insider Sold Shares Worth $736,550, According to a Recent SEC Filing

Amphastar Pharmaceuticals Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

5 months ago

Amphastar Pharmaceuticals Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Compared to Estimates, Amphastar (AMPH) Q2 Earnings: A Look at Key Metrics

Zacks

6 months ago

Compared to Estimates, Amphastar (AMPH) Q2 Earnings: A Look at Key Metrics

Amphastar Pharmaceuticals (AMPH) Tops Q2 Earnings and Revenue Estimates

Zacks

6 months ago

Amphastar Pharmaceuticals (AMPH) Tops Q2 Earnings and Revenue Estimates

Associated Press Finance

6 months ago

Amphastar: Q2 Earnings Snapshot

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2024

ACCESSWIRE

6 months ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2024

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7, 2024

ACCESSWIRE

6 months ago

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7, 2024

Argus Research

6 months ago

AMPH: Raising target price to $43.00

Argus Research

6 months ago

AMPH: Raising target price to $42.00

Why Amphastar (AMPH) is Poised to Beat Earnings Estimates Again

Zacks

6 months ago

Why Amphastar (AMPH) is Poised to Beat Earnings Estimates Again

3 Generic Drug Stocks to Watch Amid Improving Market Prospects

Zacks

6 months ago

3 Generic Drug Stocks to Watch Amid Improving Market Prospects

Argus Research

6 months ago

AMPH: What does Argus have to say about AMPH?

Argus Research

7 months ago

AMPH: Lowering target price to $39.00

GuruFocus.com

7 months ago

Insider Sale: CFO, EVP & Treasurer William Peters Sells Shares of Amphastar Pharmaceuticals ...

Insider Sale: Director Floyd Petersen Sells Shares of Amphastar Pharmaceuticals Inc (AMPH)

GuruFocus.com

7 months ago

Insider Sale: Director Floyd Petersen Sells Shares of Amphastar Pharmaceuticals Inc (AMPH)

With EPS Growth And More, Amphastar Pharmaceuticals (NASDAQ:AMPH) Makes An Interesting Case

Simply Wall St.

8 months ago

With EPS Growth And More, Amphastar Pharmaceuticals (NASDAQ:AMPH) Makes An Interesting Case

Flash News: OKX Launches 'Trade and Earn' Campaign Featuring 2,500,000 Ultiverse Tokens

GlobeNewswire

8 months ago

Flash News: OKX Launches 'Trade and Earn' Campaign Featuring 2,500,000 Ultiverse Tokens

Sustainable Construction Practices and Modular Techniques Drive Dry Construction Market to $127.69 Billion by 2029

GlobeNewswire

8 months ago

Sustainable Construction Practices and Modular Techniques Drive Dry Construction Market to $127.69 Billion by 2029

Advantech Releases FWA-3051, The Latest 1U Rackmount Edge Networking Solution with Intel® Xeon® D-2700/2800 Series

PR Newswire

8 months ago

Advantech Releases FWA-3051, The Latest 1U Rackmount Edge Networking Solution with Intel® Xeon® D-2700/2800 Series

Hydrogen Storage Market Set to Hit $6.8 Billion by 2031, registering a solid CAGR of 23% - Exclusive Report by Coherent Market Insights

GlobeNewswire

8 months ago

Hydrogen Storage Market Set to Hit $6.8 Billion by 2031, registering a solid CAGR of 23% - Exclusive Report by Coherent Market Insights

Shake Shack (SHAK) Rose after Strong Q4 Results

Insider Monkey

8 months ago

Shake Shack (SHAK) Rose after Strong Q4 Results

Flash News: OKX to List Ultiverse's Token on its Perpetual Futures Market, Expanding Trading Options

GlobeNewswire

8 months ago

Flash News: OKX to List Ultiverse's Token on its Perpetual Futures Market, Expanding Trading Options

"Green Energy" Brings Charging Piles to Mountain Villages

PR Newswire

8 months ago

"Green Energy" Brings Charging Piles to Mountain Villages

Global UV-Curable Adhesives Market Report 2024: Rising Demand in Electronics and Packaging Drives UV-Curable Adhesives Market to $605.4 Million by 2032

GlobeNewswire

8 months ago

Global UV-Curable Adhesives Market Report 2024: Rising Demand in Electronics and Packaging Drives UV-Curable Adhesives Market to $605.4 Million by 2032

MT Newswires

8 months ago

Amphastar Pharmaceuticals' Board Approves $50 Million Increase to Share Buyback Plan

Amphastar Announces Additional $50 Million Increase to its Share Buyback Program

ACCESSWIRE

8 months ago

Amphastar Announces Additional $50 Million Increase to its Share Buyback Program

Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

ACCESSWIRE

8 months ago

Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

MT Newswires

8 months ago

Amphastar Pharmaceuticals Gains US FDA Approval for Generic Bronchospasm Drug

Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol

ACCESSWIRE

8 months ago

Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol

Implied Volatility Surging for Amphastar (AMPH) Stock Options

Zacks

8 months ago

Implied Volatility Surging for Amphastar (AMPH) Stock Options

GuruFocus.com

8 months ago

Amphastar Pharmaceuticals Reports Strong First Quarter Earnings, Surpassing Analyst Revenue ...

Amphastar Pharmaceuticals First Quarter 2024 Earnings: EPS: US$0.90 (vs US$0.54 in 1Q 2023)

Simply Wall St.

8 months ago

Amphastar Pharmaceuticals First Quarter 2024 Earnings: EPS: US$0.90 (vs US$0.54 in 1Q 2023)

Amphastar Pharmaceuticals to Present at the Bank of America Securities Health Care Conference

ACCESSWIRE

8 months ago

Amphastar Pharmaceuticals to Present at the Bank of America Securities Health Care Conference

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2024 Earnings Call Transcript

Insider Monkey

9 months ago

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2024 Earnings Call Transcript

Thomson Reuters StreetEvents

9 months ago

Q1 2024 Amphastar Pharmaceuticals Inc Earnings Call

GuruFocus.com

9 months ago

Amphastar Pharmaceuticals Inc (AMPH) Q1 2024 Earnings Call Transcript Highlights: Robust Growth ...

Amphastar Pharmaceuticals (AMPH) Tops Q1 Earnings and Revenue Estimates

Zacks

9 months ago

Amphastar Pharmaceuticals (AMPH) Tops Q1 Earnings and Revenue Estimates

Associated Press Finance

9 months ago

Amphastar: Q1 Earnings Snapshot

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2024

ACCESSWIRE

9 months ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2024

Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Simply Wall St.

9 months ago

Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Will Taysha Gene Therapies, Inc. (TSHA) Report Negative Q1 Earnings? What You Should Know

Zacks

9 months ago

Will Taysha Gene Therapies, Inc. (TSHA) Report Negative Q1 Earnings? What You Should Know

Amphastar Pharmaceuticals (AMPH) Reports Next Week: Wall Street Expects Earnings Growth

Zacks

9 months ago

Amphastar Pharmaceuticals (AMPH) Reports Next Week: Wall Street Expects Earnings Growth

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024

ACCESSWIRE

9 months ago

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024

Why Amphastar (AMPH) Could Beat Earnings Estimates Again

Zacks

9 months ago

Why Amphastar (AMPH) Could Beat Earnings Estimates Again

Argus Research

9 months ago

AMPH: What does Argus have to say about AMPH?

Amphastar Pharmaceuticals (NASDAQ:AMPH) shareholders YoY returns are lagging the company's 66% three-year earnings growth

Simply Wall St.

9 months ago

Amphastar Pharmaceuticals (NASDAQ:AMPH) shareholders YoY returns are lagging the company's 66% three-year earnings growth

Amphastar Pharmaceuticals (AMPH) Stock Moves -1%: What You Should Know

Zacks

10 months ago

Amphastar Pharmaceuticals (AMPH) Stock Moves -1%: What You Should Know

Amphastar Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference

ACCESSWIRE

10 months ago

Amphastar Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference

Is Amphastar (AMPH) a Buy as Wall Street Analysts Look Optimistic?

Zacks

10 months ago

Is Amphastar (AMPH) a Buy as Wall Street Analysts Look Optimistic?

Amphastar Pharmaceuticals (AMPH) Registers a Bigger Fall Than the Market: Important Facts to Note

Zacks

10 months ago

Amphastar Pharmaceuticals (AMPH) Registers a Bigger Fall Than the Market: Important Facts to Note

Amphastar Pharmaceuticals (AMPH) Stock Sinks As Market Gains: What You Should Know

Zacks

10 months ago

Amphastar Pharmaceuticals (AMPH) Stock Sinks As Market Gains: What You Should Know

Brokers Suggest Investing in Amphastar (AMPH): Read This Before Placing a Bet

Zacks

10 months ago

Brokers Suggest Investing in Amphastar (AMPH): Read This Before Placing a Bet

Amphastar Pharmaceuticals Inc CFO, EVP & Treasurer William Peters Sells 18,136 Shares

GuruFocus.com

a year ago

Amphastar Pharmaceuticals Inc CFO, EVP & Treasurer William Peters Sells 18,136 Shares

Amphastar Pharmaceuticals Inc Director Michael Zasloff Sells 12,500 Shares

GuruFocus.com

a year ago

Amphastar Pharmaceuticals Inc Director Michael Zasloff Sells 12,500 Shares

Amphastar Pharmaceuticals to Present at the Barclays 26th Annual Global Healthcare Conference

ACCESSWIRE

a year ago

Amphastar Pharmaceuticals to Present at the Barclays 26th Annual Global Healthcare Conference

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q4 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

a year ago

Q4 2023 Amphastar Pharmaceuticals Inc Earnings Call

Amphastar Pharmaceuticals (AMPH) Surpasses Q4 Earnings and Revenue Estimates

Zacks

a year ago

Amphastar Pharmaceuticals (AMPH) Surpasses Q4 Earnings and Revenue Estimates

Amphastar Pharmaceuticals Inc Reports Robust Revenue Growth and Strong Full-Year Performance

GuruFocus.com

a year ago

Amphastar Pharmaceuticals Inc Reports Robust Revenue Growth and Strong Full-Year Performance

Associated Press Finance

a year ago

Amphastar: Q4 Earnings Snapshot

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2023

ACCESSWIRE

a year ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2023

Share on Social Networks: